Combination of vinorelbine capsules and the small molecule anti-angiogenic drug apatinib for first-line treatment of advanced triple-negative breast cancer with schizophrenia after failure of anthracycline and taxane therapy: A case report

Xue Bai, Liping Chen, Xuelian Chen, Dongcun Wang, Wenyan Kang, Lin Song, Meidi Liu, Caiwen Du · 2026

Read Combination of vinorelbine capsules and the small molecule anti-angiogenic drug apatinib for first-line treatment of advanced triple-negative breast cancer with schizophrenia after failure of anthracycline and taxane therapy: A case report by Xue Bai, Liping Chen, Xuelian Chen, Dongcun Wang, Wenyan Kang, Lin Song, Meidi Liu, Caiwen Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613308.txt.

Description

Xue Bai and seven co-authors present in 2026 the case of a woman with advanced triple-negative breast cancer and schizophrenia whose standard chemotherapy had failed. This form of breast cancer has few treatment options and a poor outlook, and her mental illness made care harder still.

The team treated her with oral vinorelbine capsules plus apatinib, a drug that chokes off the blood supply tumors build for themselves. The report explains why this pairing was chosen after anthracycline and taxane drugs stopped working. Cases like hers show how doctors improvise sound plans when the standard road closes and the patient has more than one serious illness.

Catalog record

CREATORXue Bai, Liping Chen, Xuelian Chen, Dongcun Wang, Wenyan Kang, Lin Song, Meidi Liu, Caiwen Du
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13613308

Browse the full library · About the Tower of Babel